Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
9.8%
% of IXJ's 112 holdings also in PPH
45.8%
% of PPH's 27 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.7% | 12.4% | 8.7% |
|
JOHNSON & JOHNSON | 4.7% | 6.4% | 4.7% |
|
ABBVIE INC | 4.3% | 5.9% | 4.3% |
|
MERCK & CO. INC. | 3.6% | 5.0% | 3.6% |
|
PFIZER INC | 2.0% | 4.3% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 6.7% |
 |
NOVO NORDISK A/S-B | 4.7% |
 |
ASTRAZENECA PLC | 2.9% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
 |
ROCHE HOLDING LTD | 2.8% |
|
ABBOTT LABORATORIES | 2.8% |
|
NOVARTIS AG | 2.7% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
DANAHER CORP | 2.1% |
|
AMGEN INC | 2.0% |
IXJ Underweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | -8.1% |
|
NOVARTIS AG-ADR | -4.7% |
|
ASTRAZENECA PLC-SPONS ADR | -4.6% |
|
MCKESSON CORP | -4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.5% |
|
AMERISOURCEBERGEN CORP | -4.3% |
|
BRISTOL-MYERS SQUIBB CO | -4.1% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.9% |
|
ELI LILLY & CO | -3.7% |